Top Markets
Coin of the day
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock

Polaryx Therapeutics, Inc. Common Stock

PLYX
Pozycja w akcjach #21586
Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to... Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to advancing small-molecule therapies for lysosomal storage and neurodegenerative conditions. Its developmental pipeline includes a trio of promising candidates: PLX-100, which combines PLX-200 with an ancillary supplement, targeting late infantile neuronal ceroid lipofuscinosis (LINCL) and related forms of NCL. PLX-200, a repurposed compound already utilized to address various diseases in both adult and pediatric populations. And PLX-300, derived from an edible plant, which works by activating PPARa to enhance the production of transcription factor EB. The company, established in 2014, maintains its base of operations in Paramus, New Jersey.
Cena akcji
$2.10
Ostatnia synchronizacja: 2026-08-21
Kapitalizacja rynkowa
$104.43M
Zmiana (1 dzień)
-2.10%
Zmiana (1 rok)
-
Kraj
US
Handel Polaryx Therapeutics, Inc. Common Stock (PLYX)

Kategoria

Historia stopy dywidendy dla Polaryx Therapeutics, Inc. Common Stock (PLYX)
Stopa dywidendy (TTM) dla Polaryx Therapeutics, Inc. Common Stock (symbol akcji: PLYX) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Polaryx Therapeutics, Inc. Common Stock (PLYX) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji